Year |
Citation |
Score |
2015 |
Acosta-Alvear D, Cho MY, Wild T, Buchholz TJ, Lerner AG, Simakova O, Hahn J, Korde N, Landgren O, Maric I, Choudhary C, Walter P, Weissman JS, Kampmann M. Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits. Elife. 4. PMID 26327694 DOI: 10.7554/Elife.08153 |
0.464 |
|
2015 |
Acosta-Alvear D, Cho MY, Wild T, Buchholz TJ, Lerner AG, Simakova O, Hahn J, Korde N, Landgren O, Maric I, Choudhary C, Walter P, Weissman JS, Kampmann M. Author response: Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits Elife. DOI: 10.7554/Elife.08153.019 |
0.464 |
|
2015 |
Masto VB, Lerner AG, Arastu-Kapur S. Abstract 1735: Identification of novel synthetic lethal interactions in small cell lung cancer with the proteasome inhibitor carfilzomib Cancer Research. 75: 1735-1735. DOI: 10.1158/1538-7445.Am2015-1735 |
0.365 |
|
2013 |
Lin T, Lerner A, Kirk CJ, Arastu-Kapur S. Survival Pathways Stabilized By Proteasome Inhibition Reveal PIM2 As a Novel Target For Potentiating The Anti-Myeloma Activity Of Carfilzomib Blood. 122: 4440-4440. DOI: 10.1182/Blood.V122.21.4440.4440 |
0.463 |
|
2013 |
Lowe E, Maglathlin R, Lerner A, Taunton J, Kirk CJ, Arastu-Kapur S. Blocking Protein Secretion and Degradation Is a Novel Treatment Strategy For Malignant Cells With High Protein Load Blood. 122: 4439-4439. DOI: 10.1182/Blood.V122.21.4439.4439 |
0.4 |
|
2012 |
Lerner AG, Upton JP, Praveen PV, Ghosh R, Nakagawa Y, Igbaria A, Shen S, Nguyen V, Backes BJ, Heiman M, Heintz N, Greengard P, Hui S, Tang Q, Trusina A, et al. IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metabolism. 16: 250-64. PMID 22883233 DOI: 10.1016/J.Cmet.2012.07.007 |
0.478 |
|
2009 |
Han D, Lerner AG, Vande Walle L, Upton JP, Xu W, Hagen A, Backes BJ, Oakes SA, Papa FR. IRE1alpha kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates. Cell. 138: 562-75. PMID 19665977 DOI: 10.1016/J.Cell.2009.07.017 |
0.473 |
|
Low-probability matches (unlikely to be authored by this person) |
2019 |
Lerner AG, Kovalenko M, Welch M, Cruz Td, Jones J, Wong C, Spatola B, Eberhardt M, Wong A, Fung W, Lagpacan L, Losenkova K, Yegutkin G, Soros V, Corbin J, et al. Abstract 5012: Targeting CD39 with a first-in-class inhibitory antibody prevents ATP processing and increases T-cell activation Cancer Research. 79: 5012-5012. DOI: 10.1158/1538-7445.Am2019-5012 |
0.279 |
|
2020 |
Spatola BN, Lerner AG, Wong C, Dela Cruz T, Welch M, Fung W, Kovalenko M, Losenkova K, Yegutkin GG, Beers C, Corbin J, Soros VB. Fully human anti-CD39 antibody potently inhibits ATPase activity in cancer cells via uncompetitive allosteric mechanism. Mabs. 12: 1838036. PMID 33146056 DOI: 10.1080/19420862.2020.1838036 |
0.188 |
|
2019 |
Li XY, Moesta AK, Xiao C, Nakamura K, Casey M, Zhang H, Madore J, Lepletier A, Roman Aguilera A, Sundarrajan A, Jacoberger-Foissac C, Wong C, Dela Cruz T, Welch M, Lerner AG, et al. Targeting CD39 in cancer reveals an extracellular ATP and inflammasome driven tumor immunity. Cancer Discovery. PMID 31699796 DOI: 10.1158/2159-8290.Cd-19-0541 |
0.176 |
|
2006 |
Ralston KS, Lerner AG, Diener DR, Hill KL. Flagellar motility contributes to cytokinesis in Trypanosoma brucei and is modulated by an evolutionarily conserved dynein regulatory system. Eukaryotic Cell. 5: 696-711. PMID 16607017 DOI: 10.1128/Ec.5.4.696-711.2006 |
0.162 |
|
1973 |
Lerner AG, Meng CH, Schneider KM. Selective intra-arterial vasopressin in the management of stress ulcers in childhood. Pediatrics. 51: 126-8. PMID 4684434 |
0.113 |
|
2000 |
Lerner AG, Gelkopf M, Oyffe I, Finkel B, Katz S, Sigal M, Weizman A. LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study. International Clinical Psychopharmacology. 15: 35-7. PMID 10836284 |
0.08 |
|
2001 |
Lerner AG, Skladman I, Kodesh A, Sigal M, Shufman E. LSD-induced Hallucinogen Persisting Perception Disorder treated with clonazepam: two case reports. The Israel Journal of Psychiatry and Related Sciences. 38: 133-6. PMID 11475916 |
0.067 |
|
2003 |
Lerner AG, Gelkopf M, Skladman I, Rudinski D, Nachshon H, Bleich A. Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features. International Clinical Psychopharmacology. 18: 101-5. PMID 12598822 DOI: 10.1097/01.yic.0000053665.88477.46 |
0.059 |
|
2007 |
Dowlatshahi K, Snider H, Lerner AG. Who should perform image-guided breast biopsy and treatment? American Journal of Surgery. 194: 275-7. PMID 17693264 DOI: 10.1016/j.amjsurg.2007.05.035 |
0.057 |
|
2015 |
Lerner AG, Bernabé-Ortiz A, Ticse R, Hernandez A, Huaylinos Y, Pinto ME, Málaga G, Checkley W, Gilman RH, Miranda JJ. Type 2 diabetes and cardiac autonomic neuropathy screening using dynamic pupillometry. Diabetic Medicine : a Journal of the British Diabetic Association. PMID 25761508 DOI: 10.1111/dme.12752 |
0.055 |
|
1998 |
Lerner AG, Oyffe I, Sigal M. Naltrexone-induced reduction of tobacco intake. The Journal of Clinical Psychiatry. 59: 30-1. PMID 9491065 |
0.052 |
|
2002 |
Lerner AG, Shufman E, Kodesh A, Kretzmer G, Sigal M. LSD-induced Hallucinogen Persisting Perception Disorder with depressive features treated with reboxetine: case report. The Israel Journal of Psychiatry and Related Sciences. 39: 100-3. PMID 12227224 |
0.051 |
|
2011 |
Dooley WC, Algan O, Dowlatshahi K, Francescatti D, Tito E, Beatty JD, Lerner AG, Ballard B, Boolbol SK. Surgical perspectives from a prospective, nonrandomized, multicenter study of breast conserving surgery and adjuvant electronic brachytherapy for the treatment of breast cancer. World Journal of Surgical Oncology. 9: 30. PMID 21385371 DOI: 10.1186/1477-7819-9-30 |
0.05 |
|
1995 |
Lerner AG, Gelkopf M, Oyffe I, Sigal M. Home-based inpatient treatment vs. outpatient day clinic treatment: a preliminary report in opiate-dependent patients. The Journal of Nervous and Mental Disease. 183: 715. PMID 7595435 |
0.047 |
|
2013 |
Lerner AG, Bernabe-Ortiz A, Gilman RH, Smeeth L, Miranda JJ. The "rule of halves" does not apply in Peru: awareness, treatment, and control of hypertension and diabetes in rural, urban, and rural-to-urban migrants. Critical Pathways in Cardiology. 12: 53-8. PMID 23680809 DOI: 10.1097/HPC.0b013e318285ef60 |
0.045 |
|
2002 |
Lerner AG, Gelkopf M, Skladman I, Oyffe I, Finkel B, Sigal M, Weizman A. Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approach. The Israel Journal of Psychiatry and Related Sciences. 39: 92-9. PMID 12227234 |
0.044 |
|
1997 |
Lerner AG, Gelkopf M, Sigal M, Oyffe I. Indicators of good prognosis in naltrexone treatment: A five-year prospective study Addiction Research and Theory. 4: 385-391. |
0.042 |
|
1998 |
Lerner AG, Finkel B, Oyffe I, Merenzon I, Sigal M. Clonidine treatment for hallucinogen persisting perception disorder. The American Journal of Psychiatry. 155: 1460. PMID 9766785 |
0.041 |
|
1997 |
Lerner AG, Oyefe I, Isaacs G, Sigal M. Naltrexone treatment of hallucinogen persisting perception disorder. The American Journal of Psychiatry. 154: 437. PMID 9054801 |
0.036 |
|
2001 |
Kodesh A, Finkel B, Lerner AG, Kretzmer G, Sigal M. Dose-dependent olanzapine-associated leukopenia: three case reports. International Clinical Psychopharmacology. 16: 117-9. PMID 11236070 |
0.033 |
|
2015 |
Lerner AG, Ran SL. LSD-associated “Alice in wonderland syndrome” (AIWS): A hallucinogen persisting perception disorder (HPPD) case report Israel Journal of Psychiatry and Related Sciences. 52: 67-69. |
0.033 |
|
2011 |
Lerner AG, Goodman C, Rudinski D, Bleich A. Benign and time-limited visual disturbances (flashbacks) in recent abstinent high-potency heavy cannabis smokers: a case series study. The Israel Journal of Psychiatry and Related Sciences. 48: 25-9. PMID 21572239 |
0.031 |
|
2001 |
Kodesh A, Katz S, Lerner AG, Finkel B, Sigal M. Intermittent, luteal phase nefazodone treatment of premenstrual dysphoric disorder. Journal of Psychopharmacology (Oxford, England). 15: 58-60. PMID 11277610 |
0.029 |
|
2014 |
Lerner AG, Goodman C, Bor O, Lev Ran S. Synthetic cannabis substances (SPS) use and hallucinogen persisting perception disorder (HPPD): Two case reports Israel Journal of Psychiatry and Related Sciences. 51: 277-280. |
0.029 |
|
1998 |
Finkel B, Lerner AG, Oyffe I, Sigal M. Risperidone-associated agranulocytosis. The American Journal of Psychiatry. 155: 855-6. PMID 9619165 |
0.025 |
|
1974 |
Lerner AG, Molnar JJ, Adam YG. Adenoid cystic carcinoma of the breast. American Journal of Surgery. 127: 585-7. PMID 4362663 DOI: 10.1016/0002-9610(74)90322-5 |
0.024 |
|
2014 |
Lev-Ran S, Feingold D, Frenkel A, Lerner AG. Clinical characteristics of individuals with schizophrenia and hallucinogen persisting perception disorder: a preliminary investigation. Journal of Dual Diagnosis. 10: 79-83. PMID 25392249 DOI: 10.1080/15504263.2014.906155 |
0.023 |
|
2002 |
Burak WE, Lerner AG. Importance of quality breast imaging in symptomatic women. Radiology. 222: 856; author reply 85. PMID 11867813 DOI: 10.1148/radiol.2223011228 |
0.022 |
|
1971 |
Strack PR, Newman HK, Lerner AG, Green SH, Meng CH, Del Guercio LR, State D. An integrated procedure for the rapid diagnosis of biliary obstruction, portal hypertension and liver disease of uncertain etiology. The New England Journal of Medicine. 285: 1225-31. PMID 5113711 DOI: 10.1056/NEJM197111252852204 |
0.021 |
|
2014 |
Lerner AG, Goodman C, Rudinski D, Lev-Ran S. LSD flashbacks – The appearance of new visual imagery not experienced during initial intoxication: Two case reports Israel Journal of Psychiatry and Related Sciences. 51: 307-309. |
0.02 |
|
1971 |
Lewin I, Lerner AG, Green SH, Del Guercio LR, Siegel JH. Physical class and physiologic status in the prediction of operative mortality in the aged sick. Annals of Surgery. 174: 217-31. PMID 5560845 |
0.018 |
|
2002 |
Lerner AG. Understanding breast surgery economics. American Journal of Surgery. 184: 297-8. PMID 12383886 DOI: 10.1016/S0002-9610(02)00960-1 |
0.016 |
|
1993 |
Lerner AG, Sigal M, Gelkopf M. Naltrexone abuse and risk of suicide. The Journal of Nervous and Mental Disease. 181: 706-7. PMID 8228955 |
0.011 |
|
2002 |
Lerner AG, Shufman E, Kodesh A, Rudinski D, Kretzmer G, Sigal M. Risperidone-associated, benign transient visual disturbances in schizophrenic patients with a past history of LSD abuse. The Israel Journal of Psychiatry and Related Sciences. 39: 57-60. PMID 12013711 |
0.011 |
|
2014 |
Lerner AG, Rudinski D, Bor O, Goodman C. Flashbacks and HPPD: A clinical-oriented concise review Israel Journal of Psychiatry and Related Sciences. 51: 296-302. |
0.01 |
|
2003 |
Beitsch PD, Lerner AG, Laidley AL, Tafra L, Edwards MJ. Who are we and what do we think? American Journal of Surgery. 186: 321-3. PMID 14553842 DOI: 10.1016/S0002-9610(03)00270-8 |
0.01 |
|
1999 |
Lerner AG, Stoianovici D, Whitcomb LL, Kavoussi LR. A passive positioning and supporting device for surgical robots and instrumentation Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 1679: 1052-1062. |
0.01 |
|
1992 |
Lerner AG, Sigal M, Bocalu A, Gelkopf M. Naltrexone abuse potential. The Journal of Nervous and Mental Disease. 180: 734-5. PMID 1431829 DOI: 10.1097/00005053-199211000-00012 |
0.01 |
|
1986 |
Chait MM, Lerner AG. Bouveret's syndrome presenting as upper gastrointestinal hemorrhage. The American Journal of Gastroenterology. 81: 1199-201. PMID 3491539 |
0.01 |
|
Hide low-probability matches. |